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While studying the developmental functions of the Drosophila dopamine synthesis pathway genes, we noted interesting and unexpected
mutant phenotypes in the developing trachea, a tubule network that has been studied as a model for branching morphogenesis. Specifically, Punch
(Pu) and pale (ple) mutants with reduced dopamine synthesis show ectopic/aberrant migration, while Catecholamines up (Catsup) mutants that
over-express dopamine show a characteristic loss of migration phenotype. We also demonstrate expression of Punch, Ple, Catsup and dopamine in
tracheal cells. The dopamine pathway mutant phenotypes can be reproduced by pharmacological treatments of dopamine and a pathway inhibitor
3-iodotyrosine (3-IT), implicating dopamine as a direct mediator of the regulatory function. Furthermore, we show that these mutants genetically
interact with components of the endocytic pathway, namely shibire/dynamin and awd/nm23, that promote endocytosis of the chemotactic
signaling receptor Btl/FGFR. Consistent with the genetic results, the surface and total cellular levels of a Btl-GFP fusion protein in the tracheal
cells and in cultured S2 cells are reduced upon dopamine treatment, and increased in the presence of 3-IT. Moreover, the transducer of Btl
signaling, MAP kinase, is hyper-activated throughout the tracheal tube in the Pu mutant. Finally we show that dopamine regulates endocytosis via
controlling the dynamin protein level.
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The development of the Drosophila tracheal system, an
extensively branched system of oxygen delivery tubes,
models the patterning of vasculature in mammalian angiogen-
esis, both in cellular mechanisms of directed migratory
behavior and in the conserved roles of numerous gene
products (for reviews, see Metzger and Krasnow, 1999;
Affolter and Shilo, 2000; Ghabrial et al., 2003). Detailed
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doi:10.1016/j.ydbio.2007.04.047to the identification of more than 30 genes (Affolter and
Shilo, 2000) engaged in patterning this complex structure. In
both flies and mammals, the key defining process is the
outgrowth of branches, regulated by growth factor signaling
pathways. In Drosophila, the fibroblast growth factor (FGF)
signaling pathway is utilized repeatedly to pattern the trachea
in a stereotyped fashion with branching occurring in distinct
stages: the primary and secondary branching forming through
a tightly regulated genetic program (Metzger and Krasnow,
1999) and tertiary branching arising in response to tissue
oxygen demand (Wigglesworth, 1959; Jarecki et al., 1999).
The tracheal network arises during embryogenesis from
laterally and segmentally repeated placodes each of 80–100
cells. Tracheal cells express the FGF receptor encoded by the
breathless gene (btl; Lee et al., 1996). These cells migrate
outward from a tracheal placodes in response to FGF
(Drosophila Bnl, encoded by branchless) emanating from
surrounding mesodermal cells (Sutherland et al., 1996). The
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migration and rearrangement without further cellular division
(Metzger and Krasnow, 1999; Affolter and Shilo, 2000),
making it an ideal system for studying tubular cell migration.
Disruption of FGF-FGFR signaling has a direct effect on
tracheal tubule formation. Misexpression of bnl from sources
other than the abutting mesodermal cells causes migration of
tracheal cells to the ectopic source (Sutherland et al., 1996;
Ribeiro et al., 2002), while expression of a constitutively
active Btl receptor can cause the sprouting of supernumerary
branches (Lee et al., 1996).
In the course of examining developmental roles of genes that
regulate the biosynthesis of catecholamines, dopamine (DA) in
particular, we found that abnormal embryonic tracheal pattern-
ing was a common mutant phenotype for these genes (Reynolds
and O'Donnell, 1987). This is surprising, since more typically,
DA serves as a neurotransmitter and neurohormone in Droso-
phila, as in mammals, although previous studies in both Dro-
sophila and mammals have implicated catecholamines in
developmental processes such as embryonic nuclear division
and ovarian development (Chen et al., 1994; Neckameyer,
1996, 2001; Pendleton et al., 1996; Mayerhofer et al., 1997;
Pendleton et al., 2005) such as embryonic nuclear division and
ovarian development.
The DA biosynthesis machinery is highly conserved in
mammalian and Drosophila systems. DA production requires
the tightly regulated collaboration of two enzymatic pathways.
The DA pathway itself is initiated by the conversion of tyrosine
to L-3-4-dihydroxyl-phenylalanine (L-Dopa), which is subse-
quently converted to DA (Nagatsu et al., 1964; Axelrod, 1971).
The rate-limiting step in the pathway, conversion of tyrosine to
L-Dopa, is catalyzed by the enzyme tyrosine hydroxylase (TH),
which is encoded by pale (ple) in Drosophila (Neckameyer
and White, 1993). Human and Drosophila TH share 60%
amino acid similarity (Neckameyer et al., 2005). TH catalytic
activity requires and is regulated by the cofactor, tetrahydro-
biopterin (BH4), synthesized via the pteridine pathway
(Krishnakumar et al., 2000). The initiating and limiting
component of BH4 biosynthesis, and therefore, of DA
production, is the activity of the enzyme GTP cyclohydrolase
I (GTPCH). The human and Drosophila GTPCH proteins share
80% similarity (McLean et al., 1993). Mutations in the Dro-
sophila GTPCH gene Punch (Pu) result in dose-dependent
deficiencies in DA pools (Mackay et al., 1985; Weisberg and
O'Donnell, 1986; O'Donnell et al., 1989; Krishnakumar et al.,
2000). Similarly, mutations in the human GTPCH locus lead to
the hereditary diseases hyperphenylalaninemia and Dopa-
responsive dystonia (reviewed in Thony et al., 2000). Both
Pu and ple mutations are homozygous lethal during embry-
ogenesis. A third regulatory gene of DA synthesis, Catecho-
lamines up (Catsup), acts as a negative regulator of both
GTPCH and TH. The protein encoded by Catsup contains
seven predicted transmembrane domains and functions in post-
translational modification of both enzymes. Homozygous loss-
of-function alleles of Catsup also show developmental defects
and die in an allele-dependent fashion, from embryogenesis to
pupariation (Stathakis et al., 1999).Here we demonstrate a role for the DA biosynthesis pathway
genes in regulation of tubule migration in Drosophila trachea,
and report new findings that the action of these genes is
mediated via dopamine by controlling FGFR endocytosis.
Materials and methods
Drosophila strains and genetics
The Pu mutant alleles employed in this study were generated in EMS
mutagenesis screens. The genotypes of the strains are: dp cn PuAA17 a px sp/
SM1, dp cn PuZ22 a px sp/SM1, and shv b cn PuK5-2 bw/SM1. The genetic
characteristics of these strains are reported in Mackay et al. (1985) and
Reynolds and O'Donnell (1988); all are homozygous lethal and arrest during
late embryogenesis. The homozygous lethal ple2 is a loss-of-function allele
recovered in an EMS screen (Neckameyer and White, 1993). The
homozygous lethal Catsup26 allele is a 600 base pair deletion derived from
the mobilization of a 5′ P-element insertion in CatsupKO5042 (Stathakis et al.,
1999). Pu and Catsup mutants were maintained in a CyO-GFP background
by crossing mutant flies into a w; In(2LR)noc[4L]Sco[rv9R], b1/CyO, P
{ActGFP}JMR1 balancer chromosome. Mutant fly stocks of awd j2A4 and shi2
were obtained from the Bloomington Stock Center and btl H82Δ3 was a gift
from D. Montell (Johns Hopkins University, Baltimore, MA; Lee et al.,
1996). awd j2A4 is a single P-element insertion, resulting in a completely null
genotype (Krishnan et al., 2001; Dammai et al., 2003). The insertion site
has been mapped to the 5′ untranslated region by the Drosophila genome
project (Spradling et al., 1999). Both awd j2A4 and btl H82Δ3 are homozygous
lethal and are maintained by pairing with the balancer TM3, P{ry+
t7.2=HZ2.7}DB2 Sb. The DB2 reporter gene shows β-galactosidase (β-Gal)
expression in the maxillary segment. shi2 is a temperature-sensitive allele of
shibire that encodes Drosophila dynamin (van der Bliek and Meyerowitz,
1991). Genetic recombination was used to incorporate 1-eve-1, a transgenic
line expressing the lacZ reporter gene in all tracheal cells at all stages from
the trachealess gene promoter (Perrimon et al., 1991; a gift from A. Brand,
University of Cambridge, Cambridge, UK). Transheterozygous embryos of
shi2 or ple2 with 1-eve-1 were generated by standard genetic crosses.
The y w; btl-Gal4; UAS-GFP, UAS-lacZ fly was constructed as a trachea
marker strain. The y w; btl-Gal4; UAS-btl∷GFP transgenic line expresses a
Btl∷GFP fusion protein in btl-expressing tissues, including trachea. It was
provided to the Hsu lab by T. Kornberg (University of California, San Francisco)
and has been characterized previously (Sato and Kornberg, 2002; Dammai et al.,
2003). Note that a dash (–) is used to denote a promoter/enhancer fusion with a
reporter gene while a double colon (∷) is used to denote an open-reading-frame
fusion. For example, btl-Gal4 designates the yeast Gal4 cDNA downstream of
the btl promoter; while UAS-btl∷GFP designates a btl/GFP fusion protein
coding sequence regulated by the yeast UAS enhancer element. The binary
Gal4/UAS transgenic expression system has been described (Brand and
Perrimon, 1993).
To generate Pu transgenic strains, the wild type Pu open reading frame were
cloned into the P-element transformation vector (pUAST) downstream of the
UAS enhancer element. The resulting transformation vector was then purified
and injected into w1118 embryos by Genetic Services® (Cambridge, MA) and
transgenic animals were isolated using established methodology (Spradling and
Rubin, 1982). Expression of the transgenes in trachea was achieved by mating
homozygous strains with btl-Gal4 strains.
Punch rescue constructs w, UAS-Pu; PuZ22/CyO, P{actGFP}JMR1; +/+
and w; PuZ22/CyO, P{ActGFP}JMR1; btl-Gal4 were generated separately and
crossed. Progeny with the genotype w, UAS- Pu/+; PuZ22/PuZ22; btl-Gal4/+
were then selected as embryos without constitutive (actin) GFP expression and
subjected to further analysis.
Antibodies
Rabbit anti-Drosophila GTPCH antibodies (Chen et al., 1994) were
purified using Protein A-agarose beads (BioRad, Hercules, CA) and
concentrated to 10 mg/ml. A 1:4000 dilution was used for immunohis-
tochemistry (IHC). The rabbit anti-Ple antibody has been described
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Catsup antibody has been described (Stathakis et al., 1999) and was used at
1:2500 dilution after preadsorption with wild-type embryos. The mouse
monoclonal anti-dopamine antibody (AbCam) was used at 1:5000. The
mouse monoclonal anti-dp-MAPK (Sigma) was used at 1:500. The mouse
monoclonal antibody 2A12 was obtained from the Developmental StudiesHybridoma Bank (DSHB, University of Iowa) and used at a 1:3 dilution.
Mouse monoclonal anti-Drosophila dynamin (Shibire) antibody (BD
Biosciences) was used at 1:250 for embryos and 1:300 for S2 cells in
IHC and 1:2000 in Western blotting. Mouse monoclonal anti-β-Gal (Sigma)
was used at 1:3000 for IHC. Rabbit anti-GFP (AbCam) was used at 1:200
for S2 cells in IHC and 1:2000 for Western blotting. Mouse monoclonal anti-
33A. Hsouna et al. / Developmental Biology 308 (2007) 30–43Drosophila Crumbs antibody (from DSHB, University of Iowa) was used at
1:4 dilution for IHC.
Western blot of embryonic extracts
Wild type and mutant embryos were collected from grape juice agar plates
after 17 h of egg-laying at 25 °C and dechorionated in 50% bleach for 3 min.
After rinsing in H2O, embryos were sonicated for 8 s on ice in extraction buffer
(50 mM HEPES, pH7.6, 100 mM KCl, 1 mM EGTA, 1 mM MgCl2, 1% Triton
X-100, 10% glycerol) with protease inhibitor (from Roche) and supernatants
were collected after centrifugation at 3000×g for 20 min at 4 °C. 50 μg of protein
extracts were run on 7% SDS-polyacrylamide gel, electro-blotted, probed with
anti-Drosophila dynamin (Shibire) antibody at 1:2000 (BD Biosciences), and
reprobed with anti-β-actin antibody at 1:10,000 (mouse monoclonal from
Sigma). The intensity of the bands was quantified and the relative intensities of
the dynamin bands were normalized against the actin loading control using the
Kodak Gel Doc II Software.
Immunohistochemistry
Whole-mount immunohistochemistry followed standard procedures (Hsu et
al., 2001; Dammai et al., 2003). For fluorescence staining, Alexa Fluor 488- or
546-conjugated secondary antibodies were used (Invitrogen/Molecular Probes)
at 1:200 dilution in 2-h incubation at room temperature. For color staining,
biotin-conjugated secondary antibodies (Vector) were used at 1:1000 dilution
in 2-h incubation at room temperature. Color development used the VectaStain
reagents following the manufacturer's instruction (Vector).
Pharmacological treatment of embryos
Wild-type and mutant embryos were collected for 20 min on fresh grape agar
plates, following a 90-min pre-lay. Embryos were washed in 1× PBS and
exposed to heptane for 20 s after which they were immediately soaked in 1×
PBS or 1× PBS containing DA (0.1 M; from Sigma) or 3-IT (2 mg/ml; from
Sigma) for 5 min. The dosages were pre-determined empirically to be sub-lethal.
The embryos were then transferred to fresh agar plates, placed in a humid
chamber, and incubated at 25 °C for 17–24 h.
Drosophila Schneider 2 (S2) cell culture and treatments
S2 cells (obtained from American Type Culture Collection) were maintained
in Schneider's media supplemented with 10% heat-treated FBS (Cambrex). For
immunohistochemistry, they were grown on coverslides coated with poly-L-
lysine and were transfected using Lipofectamine 2000 (from Invitrogen) with
pUC-HygMT-btl∷GFP (as described in Dammai et al., 2003). Btl∷GFP fusion
protein expression was induced with 10 μM CuSO4 for 2 h. The cells were then
treated with buffer, DA (final concentration 0.1 mg/ml) or 3-IT (final
concentration 1 mg/ml) for 12 h, fixed and stained for GFP (rabbit polyclonal
from AbCam, used at 1:200) and Drosophila Dynamin (Shibire) (mouse
monoclonal from BD Biosciences, used at 1:300). There was limited or no cell
death at these drug dosages. S2 cell extracts were prepared and Western-blottedFig. 1. Pu and Catsup are involved in tracheal development. (A) Comparison of β-G
patterns in the trachea. β-Gal expression in 1-eve-1marks all tracheal cells at all stage
14. The insets show enlarged views of individual tracheal subunits stained for Punch.
Punch fades after stage 14. Bars are 50 μm. (B) Close-up views of portions of single
(green). Crb is a transmembrane protein and Punch overlaps with Crb completely in th
addition to some intracellular localization (arrowhead). At stage 15, peripheral locali
(open arrow). Bars are 10 μm. (C) y w embryos were stained with anti-Ple or anti-C
subunits with Ple or Catsup expression. The higher level of general staining indicate th
of indicated genotypes were stained with a tracheal lumen-specific antibody 2A12. Un
(a) y w represents wild-type. The major tracheal branch that runs along the length of t
alleles Z22 and K5-2 show disrupted tracheal network. The insets highlight ectopi
collected at 25 ° for 7 h and then incubated at 30 ° for 7 h. The inset highlights ecto
branches (arrowheads). (f,g) TwoCatsup26mutant embryos showingmoderate and sev
trunk, while panel g shows almost no branch migration. (h) Ventral view of a btlH82as described previously (Hsu et al., 2001), and probed with anti-GFP (rabbit
polyclonal from AbCam, used at 1:2000) and reprobed with anti-Drosophila
dynamin (Shibire) antibody (mouse monoclonal from BD Biosciences, used at
1:2000) and with anti-β-actin antibodies (mouse monoclonal from Sigma, used
at 1:10,000). The intensity of the bands was quantified using the Kodak Gel Doc
II Software.
Results
Punch is expressed in the trachea during the migratory phase
of development
Specific expression of Punch in the trachea has been noted
(Samakovlis et al., 1996; Chen, 1995). However, the correla-
tion between DA synthesis and tracheal development has not
been explored. As a first step toward elucidating the role of
Punch in tracheal development, we analyzed more closely its
temporal and spatial expression patterns. For comparison, the
tracheal cells were marked by a transgenic line 1-eve-1 that
expresses β-Galactosidase (β-Gal) in all tracheal cells at all
stages, under control of the trachealess promoter (Perrimon et
al., 1991). Tracheal development starts at the embryonic stage
10 with the formation of 10 placodes on each side of the
embryos. These ectodermal placodes start invaginating inward
at stage 11 (1-eve-1 in Fig. 1A) and begin to extend branches at
stage 12. These branches continue to extend and connect with
the neighboring subunits during stage 13 through stage 15,
until the stereotypic network of primary and secondary tubules
are formed at stage 16. We found that strong Punch expression
in the trachea encompasses only the mid-phase of tracheal
development. Compared with the pan-tracheal reporter expres-
sion in 1-eve-1, Punch expression is transient. It starts weakly
at stage 11 and becomes most abundant from stage 12 to stage
14, coinciding with the active phase of tracheal branch migration
(Fig. 1A). It fades after stage 15, when tubule extension is
complete. To determine more precisely the subcellular localiza-
tion of Punch, the trachea were double-stained for Punch and the
transmembrane protein Crumbs (Crb). Enlarged views of
portions of individual tracheal subunits are shown in Fig. 1B.
At stage 12, Punch in the developing trachea completely
overlaps with Crb, indicating localization at or near the cell
periphery. The peripheral localization of Punch is maintained
through stage 14, in addition to some intracellular staining (red
staining; arrowhead in the inset). At stage 15, when tracheal
lumen begins to expand, weak peripheral localization of Punchal (directed by the trachea-specific trachealess promoter) and Punch expression
s while Punch is expressed most abundantly in the trachea from stage 12 to stage
Arrows point to the site from which the dorsal trunk extends. The expression of
tracheal subunits at stage 12, 14 and 15, double stained for Punch (red) and Crb
e trachea at stage 12. At stage 14 Punch still shows extensive overlap with Crb in
zation of Punch is diminished (arrow) with an increased expression in the lumen
atsup antibodies, as indicated. The insets show enlarged views of two tracheal
at the two proteins are expressed in multiple tissues. Bars are 10 μm. (D) Embryos
less specified, all embryos are oriented with anterior to the left and dorsal side up.
he embryo, dorsal trunk, is marked (DT). (b,c) Embryos homozygous for two Pu
c branches (arrowheads). (d) shi2 temperature-sensitive mutant embryos were
pic branches (arrowheads). (e) An awdj2A4 mutant. The inset highlights ectopic
ere phenotypes, respectively. Empty arrows in panel f mark the gaps in the dorsal
Δ3 mutant embryo showing little branch migration. Bars are 50 μm.
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seen in the lumen (empty arrow in the inset). Intracellular and
lumen Punch expression becomes barely detectable at stage 16
(data not shown). The significance of lumen staining at stage 15
is not clear at this time but may reflect the role of L-Dopa in
cross-linking lumen cuticles (Wright, 1987) and that the Punch-
containing enzymatic complex may function extracellularly for
this developmental role.
We also detected tracheal expression of the other two DA
synthesis pathway components Ple and Catsup (Fig. 1C). It
should be noted that the expression of these genes includes
strong maternal contributions (Stathakis et al., 1999; Neck-
ameyer and White, 1993; Neckameyer et al., 2000). Thus,
although the two antibodies have proved specific (Stathakis et
al., 1999; Neckameyer et al., 2000, 2001), immunostaining of
the embryos shows general staining in multiple tissues.
Nonetheless, above-background staining in the trachea can be
observed (Fig. 1C, insets) throughout tracheal development for
both proteins.
DA synthesis pathway mutants exhibit tracheal development
phenotypes
Specific expression of Punch in the tracheal cells during
branch migration suggests a role in tracheal morphogenesis. In
our initial examination of the tracheal network, monoclonal
antibody 2A12 against a lumen antigen was used (Fig. 1D).
Compared to wild-type (y w; Fig. 1Da), Pu mutants show
misdirected tubules and ectopic branching, in addition to
disruption of the dorsal trunk (Figs. 1Db–c). These phenotypes
were generated by multiple alleles and in both heterozygotes and
homozygotes. The examples shown are embryos developed
through stage 14–15, as judged by well-developed midgut (not
shown), in order to avoid secondary effects from early
embryonic defects. These ectopic branching phenotypes are
similar to those observed in mutants of Drosophila metastasis
suppressor Nm23 homolog (awd) and dynamin (shi), which
cooperate in internalizing and down-regulating FGFR (Btl)
(Dammai et al., 2003; Figs. 1Dd–e). By contrast, mutants of
Catsup, which antagonizes Pu, exhibit phenotypes lacking
tracheal branches. These lack-of-migration phenotypes of
Catsup mutants range from a few gaps in the dorsal trunk (Fig.
1Df) to an almost complete lack of tubule formation (Fig. 1Dg).
No Pu-like ectopic branches are observed in these mutants. The
Catsup phenotypes are reminiscent of those observed in the btl
mutants (see Fig. 1Dh as an example; Lee et al., 1996).
DA synthesis pathway gene functions regulate tracheal cell
migration
Lumen staining using 2A12 monoclonal antibody is useful
for observing overall structure of the tracheal network, but the
cellular behavior underlying the branching defects cannot be
discerned. For example, gaps in the dorsal trunk may result from
mis-directed tubule migration that fails to connect with the
lateral subunits (ectopic migration) or from lack of migration.
That is, apparently similar phenotypes can result from oppositecellular behaviors. We therefore combined the mutant genes of
interest with the 1-eve-1 transgene that marks all tracheal cells.
1-eve-1 alone showed limited or no tracheal phenotype
(Dammai et al., 2003; Fig. 2A). In Pu mutants, ectopic looping
and branch migration are observed (Figs. 2B and C).
Importantly, in severely disrupted trachea, gaps in the dorsal
trunk are always accompanied by mis-directed tracheal cells
(arrow in Fig. 2C). These phenotypes are similar to those
observed in the shi and awd mutants (Figure S1) that are known
to result in ectopic migration (Dammai et al., 2003). In the most
extreme cases there was a complete loss of tracheal network
while rounded “run-away” tracheal cells were seen throughout
the embryos (Fig. 2D). Note that for these phenotypic analyses,
we only documented late-stage embryos with developed body
parts such as gut (empty arrowhead in Fig. 2C) or mandible
structures (brackets in Figs. 2C and D), in order to avoid
complications from early embryonic defects. The Pu pheno-
types can be rescued by exogenously expressing a UAS-Pu
transgene controlled by btl-GAL4 in the trachea (Fig. 2E), even
at the suboptimal expression temperature of 18 °C. Incubation at
25 °C resulted in a greater extent of rescue (fewer ectopic
migration phenotypes) and the appearance of the opposite
phenotype (lack of migration). Induction of opposite pheno-
copies by loss-of-function and over-expression of Pu strongly
supports the notion that Pu has a specific dosage-dependent role
in regulating tubule migration. These results indicate that the
tracheal phenotypes in Pu mutants are the result of defective Pu
function in the trachea, not indirect effects from early patterning
or from neighboring tissues. The effectiveness of the transgene
expression was confirmed by measuring the tyrosine hydro-
xylase activity in the embryonic extracts (Supplementary Figure
S2). Conversely, the Catsup mutant showed lack-of-migration
phenotypes similar to that in btl mutants (Figs. 2F and G and
Figure S1). Note that there are no ectopic tracheal cells
emanating from the tracheal tube ends at the gaps of dorsal
trunk, indicating that these gaps result from lack of migration,
not ectopic migration.
Interestingly, heterozygous mutants of ple showed similar
ectopic migration phenotypes (Fig. 2H) as in Pu mutants. Note
that heterozygous ple was examined for tracheal phenotypes
because homozygous ple exhibited severe early embryonic
defects. Besides ectopic migration phenotypes, we often
observed in ple mutants (Fig. 2I), and less frequently in Pu
mutants (Fig. 2B), the appearance of convoluted dorsal trunks.
Such phenotypes have been linked to defects in secretion and
deposition of cuticle chitin in the tracheal lumen (Luschnig et
al., 2006; Wang et al., 2006). It is therefore worth noting that
L-Dopa, the direct enzymatic product of Pale/TH, is required
for cuticle cross-linking (Wright, 1987). However, cuticle
deposition and lumen formation are initiated at late stage 14.
As such, this aspect of the Pu and ple function is temporally
distinct from the earlier tubule migration function.
DA directly regulates tracheal cell migration
Since the product of Punch/GTPCH enzymatic function,
BH4, is a cofactor of the Pale enzyme (TH), which in turn is a
Fig. 2. Tracheal cell migration defects in DA synthesis pathway mutants. The embryos were stained for β-Gal. Unless specified, all mutants are homozygotes marked
by the 1-eve-1 transgene that expresses β-Gal under control of the trachealess promoter. All embryos are oriented with anterior to the left and dorsal side up. (A)
1-eve-1 represents wild-type. (B–D) Mutant embryos homozygous for two Pu alleles AA17 and Z22. In inset panel Bb, arrows point to ectopically migrating
branches and tracheal cells. Sharp arrows point to ectopic looping of the dorsal branches. Bracket marks convoluted dorsal trunk. Panel Cc shows severe disruption of
the tracheal network with abnormal branching and sprouting. Arrow points to the misguided branch emanating from the truncated dorsal trunk. Panel Dd shows a
severe Pu mutant; rounded “run-away” tracheal cells can be identified (arrowheads). (E) Rescue of Pu phenotypes by Pu transgene expression in trachea. Wild-type
Pu expression in Pumutant background gives three broad phenotypic classes as indicated. w; PuZ22/PuZ22; btl-Gal4 or w, UAS-Pu; PuZ22/PuZ22; +/+ each gave similar
distribution of phenotypes, thus only w; PuZ22/PuZ22; btl-Gal4 was tabulated as the parental Pu mutant. The above two lines were crossed to generate the rescue lines,
as described in Materials and Methods. The embryos were incubated at 18 °C or 25 °C to control the expression level of the Pu transgene. (F–G) Mild and severe
phenotypes of Catsup mutant showing missing branches and stunted branch migration. Note that there is no ectopic branching at or near the gaps in tracheal tubes in
these mutants, indicating loss-of-migration. (H) A ple heterozygote showing moderate tracheal phenotypes similar to those in Pu mutants. (Hh) Sharp arrow points to
ectopic looping, arrow points to ectopically migrating branches at the breakage point and arrowhead points to ectopically migrating cells. (I) A ple heterozygote
showing convoluted tracheal trunk (bracket). Bars are 50 μm.
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tracheal phenotypes observed in Pu and ple mutants suggest
that DA itself may play a role in modulating tracheal
development. Indeed, DA is enriched in the wild-type trachea
(Fig. 3A) but is absent in the Pu mutant (Fig. 3B). The pattern
is consistent with the enrichment of Pu in tracheal cells (Fig.
1A). We next examined whether DA has a direct role in
tubulogenesis. In this assay, a transgenic line expressing a GFP
reporter gene driven by the btl enhancer was used to allow for
examination of live embryos. The Catsup (lack of migration)
and Pu and ple (ectopic migration) phenotypes were repro-
duced by DA and 3-iodotyrosine (3-IT, a TH inhibitor)treatments, respectively (Figs. 3C–F). Note that the dosages
of DA and 3-IT were sublethal as the embryos developed
normally into late stages. DA treatment resulted in gaps in the
dorsal trunk (empty arrow in Fig. 3D) accompanied by clumps
of tracheal cells that did not migrate out of the dorsal trunk
(empty arrowheads in Fig. 3D). The clumping of tracheal cells
in the dorsal trunk is in contrast to the normal and 3-IT treated
samples that show clear and hollow lumenal space (sharp
arrows in Figs. 3C and E). This phenotype is consistent with
reduced tracheal cell migration. By contrast, in 3-IT treated
embryos, misdirected branches (arrow in Fig. 3E) and
ectopically localized tracheal cells were observed (bracket in
36 A. Hsouna et al. / Developmental Biology 308 (2007) 30–43Fig. 3E). The mislocalized tracheal cells are rounded and are
not organized into tubule structures. All phenotypic classes
generated by DA and 3-IT are summarized in Fig. 3F. They areconsistent with the lack-of-migration (DA treatment) and
ectopic migration (3-IT treatment) mutant phenotypes
described in Fig. 2.
Table 1
Genetic interactions between DA synthesis and Btl endocytosis pathway genes
Genotypes n % Normal % Ectopic migration phenotype a % Lack-of-migration phenotype a
Moderate Severe Moderate Severe
PuAA17/+; 1-eve-1/+ 24 16 71 13 0 0
awdJ2A4, 1-eve-1/+ 26 19 69 12 0 0
shi2/+ or Y; 1-eve-1/+ 21 10 66 24 0 0
PuAA17/+; 1-eve-1/awdJ2A4, 1-eve-1 19 0 53 47 0 0
shi2/+ or Y; PuAA17/+; 1-eve-1/+ 17 0 53 47 0 0
btlH82D3, 1-eve-1/+ 25 16 0 0 60 24
Catsup26/+; 1-eve-1/+ 21 33 0 0 67 0
Catsup26/+; 1-eve-1/btlH82D3, 1-eve-1 18 0 0 0 55 45
PuAA17/+; 1-eve-1/btlH82D3, 1-eve-1 22 41 46 0 13 0
Catsup26/+; 1-eve-1/awdJ2A4, 1-eve-1 17 35 36 5 24 0
PuZ22/+; 1-eve-1/+ 21 33 57 10 0 0
PuZ22/+; 1-eve-1/awdJ2A4, 1-eve-1 15 0 46 54 0 0
shi2/+ or Y; PuZ22/+; 1-eve-1/+ 16 0 44 56 0 0
PuZ22/+; 1-eve-1/btlH82D3, 1-eve-1 20 35 35 5 25 0
Catsup26/PuAA17 21 57 38 0 5 0
Catsup26/PuZ22 19 74 26 0 0 0
a As defined in Fig. 2 and Figure S1. Moderate phenotype is defined as identifiable defects in tubule structures while the overall tubular network is intact. Severe
phenotype is defined as lack of overall tracheal network due to disruption of organized tubule movement (ectopic migration) or severe blockade of migration.
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We have previously shown that awd and shi cooperate in
internalizing Btl, thus limiting the chemotactic signaling
strength (Dammai et al., 2003). The striking phenotypic
similarities between Pu/ple and awd/shi, as well as between
Catsup and btl, suggest that DA synthesis pathway components
may also modulate the FGFR signaling. If this hypothesis is
correct, Pu and ple mutants are expected to increase the FGFR
level, resulting in ectopic migration, while in Catsup mutants,
the FGFR level should be down-regulated, resulting in reduced
migration. Therefore, Pu should exacerbate, and Catsup rescue,
the phenotypes of awd and shi; while reduced dosage of FGFR
(in btl mutant) should rescue Pu but exacerbate Catsup. Since
we have observed that the tracheal developmental functions of
these genes of interest are partially haplo-insufficient (Dammai
et al., 2003; data not shown), a simple transheterozygous
analysis was conducted. All mutant alleles are marked with the
1-eve-1 transgene for visualizing tracheal cells. The severity and
characteristics of ectopic migration and lack-of-migration
phenotypes are defined in Fig. 2 and Supplemental Figure S1.
As shown in Table 1, PuAA17 and awd j2A4 heterozygotes
showed 84% and 81% mutant embryos with ectopic migration
defects, respectively, while combined heterozygous and hemi-
zygous shi2 (progenies of X-linked homozygous shi2 females
crossed with wild-type males) showed 90% embryos withFig. 3. Tracheal development can be modified with DA and a TH inhibitor in wild
double-staining with anti-DA (green) and anti-β-Gal (red) antibodies. DA is enriche
btl-GAL4 and UAS-GFP transgenes were collected at 25 °C and mock treated (con
fluorescence microscope. The GFP reporter gene is expressed in all tracheal cells. A
mock-treated embryo displays an orderly patterning of tracheal architecture. The sharp
the dorsal trunk (empty arrow). The enlarged view shows accumulation of non-migrat
(E) A 3-IT treated embryo showing ectopic branches (arrow). The enlarged view sho
The sharp arrow points to a well-formed lumen. (F) Quantification of the above rec
minimal early developmental defects and increased embryo viability. Only embryos s
panels C–E are 50 μm.ectopic migration phenotypes. Transheterozygotes of PuAA17-
awd j2A4 and P uAA17-shi2 (the latter includes hemizygous shi2)
resulted in 100% penetrance with greatly enhanced severity.
Conversely, btl H82Δ3 and Catsup26 heterozygotes showed 84%
and 67% embryos with lack-of-migration phenotypes, respec-
tively, while btl H82Δ3-Catsup26 transheterozygotes resulted in
100% penetrance for the same phenotype and with enhanced
severity. When mutations generating opposite phenotypes were
combined, as in PuAA17-btl H82Δ3 or Catsup26-awd j2A4 transhe-
terozygotes, the resulting severity of the respective phenotypes
was greatly reduced. The same analyses were performed with
another Pu allele PuZ22 and they showed the same pattern of
genetic interactions. As a validation of the genetic interaction
scheme, we combined heterozygous Catsup with either of the
two Pu alleles; the transheterozygotes showed improved ectopic
or lack of migration phenotypes. In summary, btl allele can
rescue different Pu alleles but Pu phenotypes are exacerbated
by awd and shi. By contrast, the Catsup phenotype was exac-
erbated by btl but rescued by awd.
To examine whether dopamine synthesis mutants affect Btl/
FGFR signaling, we examined the activity of MAP kinase
(MAPK), the main transducer of FGFR signaling, within the
tracheal cells. In wild-type (1-eve-1), activated MAPK (doubly-
phosphorylated MAPK, dp-MAPK), is detected only in the
migrating tip cells (arrowheads in Fig. 4A). In Pumutants (Figs.
4B and C), there are significantly elevated levels of dp-MAPK-type embryos. (A,B) 1-eve-1 or PuAA17; 1-eve-1 embryos were processed for
d in the wild-type trachea but absent in Pu mutant. (C–F) y w embryos carrying
trol) or treated with DA or 3-IT. Stage 15–16 embryos were examined under a
ll embryos are shown with dorsal side on the left and anterior to the top. (C) A
arrow points to well-formed lumen. (D) A DA-treated embryo showing a gap in
ing cells (empty arrowheads) clustered in the dorsal trunk, obstructing the lumen.
ws ectopically located and abnormally shaped (rounded) tracheal cells (bracket).
orded phenotypes (C–E). The drug exposure protocol was optimized to ensure
urviving past stage 14 were counted. Scale bars in panels A and B are 10 μm; in
Fig. 4. MAPK activation levels in DA synthesis pathway mutants. 1-eve-1, PuAA17; 1-eve-1, or Catsup26; 1-eve-1 embryos were processed for double staining with
anti-dp-MAPK and anti-β-Gal antibodies. In wild-type embryos (A), dp-MAPK is detected in the migrating tip cells (arrowheads). In Pu mutants (B,C), dp-MAPK is
over-expressed in all tracheal cells. In Catsup mutant embryos (D) dp-MAPK is not detectable in the tracheal cells, especially not in the stunted tube ends (empty
arrows).
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phenotype. By contrast, in Catsup mutant, dp-MAPK is not
detected in all tracheal cells, especially at the stunted tracheal
tube ends (empty arrows in Fig. 4D). Therefore, the Pu ectopic
migration phenotype can be correlated with the increased
MAPK activity, while the Catsup lack-of-migration phenotype
is consistent with reduced MAPK activity.
The observed genetic interactions between Pu and endocytic
pathway mutants (awd and shi) raised the interesting prospect
that DA synthesis pathway may also be involved in Btl/FGFR
endocytosis in tracheal cells. To test this model, we first
examined the expression of a Btl∷GFP fusion protein expressed
in the trachea. This fusion protein has been used in previous
studies and has been shown to be functional (Sato and
Kornberg, 2002; Dammai et al., 2003). In the wild-type (1-
eve-1) embryo without treatment, there is localization of
Btl∷GFP at the cell periphery as well as localization in
intracellular vesicles (Fig. 5A). With DA treatment, there is a
significant reduction in membrane Btl∷GFP and a concomitant
increase in the Btl∷GFP-containing vesicles, both in size
(arrowheads in Fig. 5B) and in number (Fig. 5D). By contrast,
when the embryos are treated with 3-IT, there is an increased
level and a more defined appearance of the peripheral Btl∷GFP
(i.e. sharper outlines of the tracheal cells; arrows in Fig. 5C) and
a decrease in intracellular vesicular Btl∷GFP (Fig. 5D).
To better quantify the response of Btl-GFP expression
levels to drug treatments, we repeated the assays in cultured
Drosophila cells (Fig. 6A). In untreated S2 cells stably
transfected with the btl∷GFP vector, the Btl∷GFP fusion
protein is present mostly in the cytoplasm with some surface
localization. DA treatment resulted in reduction of Btl∷GFP
while 3-IT treatment resulted in increased accumulation of
Btl∷GFP in the cell periphery. Changes in total Btl∷GFP
levels upon drug treatments were confirmed by Western
blotting (Fig. 6B, top panels). Taken together, it appears that
DA can promote internalization and down-regulation of Btl
while blocking DA synthesis results in over-accumulation of
Btl.DA regulates the level of dynamin
The results so far indicate that the function of Pu in tracheal
morphogenesis is mediated through the action of DA, which in
turn promotes internalization and turnover of the chemotactic
receptor Btl/FGFR. To further explore the role of Pu and DA in
regulating the endocytic pathway, we first examined the
expression of Shi/dynamin in DA or 3-IT treated cells. As
shown in Fig. 6A (middle panel), DA treatment resulted in
increase of Shi/dynamin levels in S2 cells with pronounced
peripheral localization (arrows), while 3-IT caused a dramatic
reduction. The change of dynamin expression levels is con-
firmed by Western blotting (Fig. 6B, middle panels). We next
examined whether this regulatory event occurs in the trachea
(Fig. 7A). In wild-type (1-eve-1) embryos, Shi shows enriched
expression in tracheal cells, and within the tracheal cells, Shi is
abundant at the cell periphery. DA treatment results in a slight
enrichment of the peripheral localization in tracheal cells as well
as in the neighboring non-tracheal cells. In Pu mutants, Shi
expression is diffused and reduced. DA treatment rescued the
Shi protein expression level in the Pu mutant. Importantly, we
show that DA treatment could also rescue the tracheal defects in
Pu mutants (Fig. 7B). To confirm that the Shi/dynamin
expression is regulated by the DA synthesis pathway compo-
nents in vivo, we examined the Shi/dynamin protein levels in
the embryonic extracts from different mutants. As shown in Fig.
7C, the two Pu mutants show 40–60% reduction in Shi/
dynamin. The ple2 allele, a hypomorph, show 23% reduction
while the Catsup26 allele show an 83% increase.
Discussion
DA regulates cell migration
In this report, we demonstrate that genes involved in DA
biosynthesis also regulate tracheal cell migration, and that
this function is mediated by DA. This is unexpected since DA
is normally associated with neuronal function. However, we
Fig. 5. Dopamine promotes internalization of Btl receptor. (A–C) Embryos of transgenic flies btl-GAL4; UAS-btl∷GFP were treated with buffer (control), DA or 3-IT
and observed for Btl∷GFP fusion protein expression. Anterior is to the left and the dorsal side is up. All images were acquired using identical settings to ensure
accurate quantification. Middle panels show enlarged views of the indicated areas in top panels. Arrows in the middle panels point to the position of three cells further
enlarged in the bottom panels. (A) A stage 15 embryo shows normal Btl-GFP distribution at plasma membrane and some cytoplasmic localization in vesicles. (B) A
stage 15 embryo treated with DA. The level of membrane Btl-GFP is greatly reduced. (C) A stage 15 embryo treated with 3-IT. Btl∷GFP shows more pronounced
surface localization. (D) Quantification of vesicle numbers per cell in DA and 3-IT treated vs. control embryos. To avoid cell- and position-specific variations, GFP-
containing vesicles are counted in cells at the same position of multiple embryos. Error bars show standard error (control, n=7 individual cells; 3-IT-treated, n=9
individual cells; DA-treated, n=8 individual cells; each data set was acquired from a minimum of 4 representative embryos). The 3-IT and DA treated embryos display
significantly reduced and increased number, respectively, when compared to untreated control. **denotes statistically significant differences as compared to the control
(pb0.05).
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because of the strong and highly specific expression of Punch
in tracheal cells during the migratory phase of tracheal
development (Fig. 1). In addition, the ectopic migration
tracheal phenotypes in Pu/GTPCH mutants can be rescued
by expressing a Pu/GTPCH transgene in developing trachea
using a btl promoter, demonstrating the trachea-specific func-
tion of the DA pathway (Fig. 2E). Moreover, the expression of
this transgene shows a dosage-dependent progression of
phenotypic outcomes. That is, mild expression rescues ectopicmigration, while over-expression tips the balance to blocked
migration.
The product of GTPCH enzymatic activity, BH4, is also a
stabilizing cofactor of nitric oxide synthase (NOS), which is
needed for hypoxia-induced outgrowth of terminal tracheal
branches (Jarecki et al., 1999; Wingrove and O'Farrell, 1999).
However, the Pu mutant phenotypes reported here are most
likely unrelated to this developmental process because of the
following reasons: (1) Terminal branching occurs near the end
of embryogenesis and during larval development (Jarecki et al.,
Fig. 6. DA promotes endocytosis of Btl/FGFR in S2 cells. S2 cells were transfected with plasmids expressing Btl∷GFP fusion protein, treated with the indicated agents
and either (A) double stained for GFP and Shi/dynamin or (B) processed for Western blotting. (A) Without drug treatment (control), Btl∷GFP fusion protein is mostly
internal with some surface localization. These cells also express endogenous Shi/dynamin. DA treatment resulted in significant reduction in Btl∷GFP level and an
increase in Shi/dynamin level as well as more pronounced peripheral localization of Shi/dynamin (arrows). 3-IT treatment resulted in increased Btl∷GFP level near the
cell periphery and concurrent reduction in Shi/dynamin level. (B) Western blot for Btl∷GFP (using anti-GFP antibody) and Shi/dynamin in lysates from the cells
treated as in panel A. The blot was reprobed for β-actin as a loading control. The numbers under the Btl:GFP and dynamin protein lanes indicate the relative protein
levels (normalized to the β-actin controls).
Fig. 7. Dynamin level is regulated by DA synthesis pathway components in the trachea. (A) Drosophila embryos of the genotypes 1-eve-1 (representing wild-type) or
PuAA17; 1-eve-1 (Pu) were double stained for β-Gal and dynamin. 1-eve-1 and Pumutant embryos were treated with either H2O or DA. Anterior is to the left and dorsal
side is up. Images are zoomed-in view of two tracheal subunits. In untreated wild-type (1-eve-1) trachea, dynamin is enriched at the cell periphery. DA treatment (1-
eve-1+DA) slightly increased peripheral localization of dynamin in wild-type in both tracheal and neighboring cells. In the Pu mutant, dynamin level is reduced. DA
treatment (Pu+DA) restored the level of dynamin. (B) PuAA17; 1-eve-1 embryos were treated with either H2O or DA (DA). Tracheal phenotypes were examined by
staining for β-Gal. DA treatment rescued the Pu phenotype. (C) Total embryonic protein extracts from the indicated strains were Western-blotted for Shi/dynamin and
reprobed for β-actin. Numbers under the protein lanes are the relative levels of dynamin normalized to the β-actin controls.
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primary and secondary branch migration occur during mid-
embryogenesis. (2) Mutations in ple, which has no role in NOS
function, also results in ectopic migration phenotypes (Fig. 2H).
(3) DA and the DA pathway inhibitor can phenocopy the
genetic mutants (Fig. 3). (4) DA treatment can rescue Pu/
GTPCH mutant phenotypes (Fig. 7B), implicating a direct role
of DA in primary and secondary branch migration. Interest-
ingly, DA is enriched in the trachea (Fig. 3).
An inhibitory role for DA in the regulation of cell migration
has been reported for a number of cell types over recent years.
Yasunari et al. (1997, 2003) have demonstrated that DA is
capable of blocking the migration of vascular smooth muscle
cells, a factor in the formation of atherosclerotic lesions, in a
process mediated through the D1 class of DA receptors. DA
also was reported to interfere with activated neutrophil
transendothelial migration (Sookhai et al., 2000). Similarly,
DA, acting through D1 receptors, is reported to reduce the
migration of regulatory T cells in damaged neural regions,
thereby providing protection against T cell-mediated neurode-
generation (Kipnis et al., 2004). Finally, DA acting through the
D2 class of DA receptors, can inhibit tumor angiogenesis in
highly vascularized gastric and ovarian tumors (Basu et al.,
2001, 2004; Chakroborty et al., 2004). It would be interesting to
determine whether the mammalian GTPCH-TH-DA enzymatic
pathways also have a non-neurological function in modulating
tubulogenesis during development.
The modulation of surface FGFR by DA is dynamin-dependent
We found that DA pathway mutants show tracheal abnorm-
alities that are strikingly similar to the perturbations of tracheal
cell migration in embryos with abnormalities in FGF signaling.
Diminution of DA expression in Drosophila embryos, either by
mutations (Pu and ple) or by pharmacological depletion (3-IT
treatment), has dramatic effects on the stereotyped migratory
behavior of tracheal cells and patterning of the resulting
branched structure. We observed that entire branches areFig. 8. A model for the action of DA synthesis pathway genes. In wild-type cells (mid
Shi/dynamin, while the stability of Shi/dynamin is regulated by DA, presumably th
when DA synthesis is blocked by 3-IT, Shi/dynamin level is reduced, resulting in ove
presence of exogenously added DA, the level of Shi/dynamin is increased, resultingmisdirected and individual cells move away from the tracheal
branches, a phenotype we term “run-away cells”. Under
conditions of excess DA, via mutations (Catsup) or pharmaco-
logical modification (DA treatment), the converse phenotype,
one of blocked migration, is evident. This phenotype is often
associated with clustering of tracheal cells near the stunted ends
of tracheal tubes. These opposing phenotypes are correlated with
the increased or decreased levels of MAPK activation, the
mediator of FGFR signaling (Fig. 4).
Our data further demonstrate that DA regulates FGF receptor
turnover. We show that Btl∷GFP fusion protein is down-
regulated in the presence of DA and up-regulated in the
presence of 3-IT, either in trachea or in cultured S2 cells (Figs. 5
and 6). These results are consistent with the model that DA
promotes internalization of Btl/FGFR, leading to its degradation
through the endocytic pathway. The role of DA in internaliza-
tion of FGFR is further suggested by the genetic interaction
between the DA synthesis and endocytic pathway genes.
Mutations in the human tumor suppressor nucleoside dipho-
sphate kinase (NDK) gene (nm23) are strongly associated with
tumor metastatic activity (Steeg et al., 1988; Freije et al., 1997).
Its functional homolog in Drosophila, abnormal wing discs
(awd) (Biggs et al., 1990), has been shown to genetically
interact with a temperature-sensitive allele of the shibire gene
(shits), which encodes dynamin (Krishnan et al., 2001), a large
GTPase required for the formation of clathrin-coated endocytic
vesicles (Kosaka and Ikeda, 1983; van der Bliek and
Meyerowitz, 1991). Dammai et al. (2003) first demonstrated a
function for awd/nm23 in the migratory phase of tracheal
development and functional interactions with shi/dynamin that
are required for the modulation of FGFR/Btl levels in tracheal
cells. In this report, we show that Pu and ple phenotypes are
exacerbated by awd and rescued by btl, while the Catsup
phenotypes are rescued by awd but exacerbated by btl (Table
1). These results indicate that Pu/GTPCH and Ple/TH, and by
extension, DA, are positive regulators of endocytosis.
We have extended this analysis by implicating direct
involvement of DA in regulating the Shi/dynamin protein itself.dle), the surface level of Btl/FGFR is modulated by endocytosis via the action of
rough a DA-receptor mediated signaling event. In Pu or ple mutants (right), or
r-accumulation of Btl/FGFR and ectopic migration. In Catsupmutants, or in the
in down-regulation of surface Btl/FGFR and reduced migration.
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kumar et al., 2000), result in reduction of the Shi/dynamin levels
(Fig. 7) and, in consequence, the subsequent accumulation of
FGFR/Btl in the plasma membranes of tracheal cells, thus
accounting for ectopic migratory behavior of these mutant
cells. Importantly, down-regulation of Shi/dynamin level in
the Pu mutants can be rescued by treatment with DA. A direct
correlation between DA and dynamin levels is also demon-
strated in cultured S2 cells (Fig. 6). Thus, the genetic and
pharmacological evidence in this report supports the hypothesis
that the diminished DA pools that accompany loss-of-function
mutations in the Pu/GTPCH and ple/TH genes result in deficits
of DA-mediated signaling necessary for Shi/dynamin accumu-
lation. The function of the DA synthesis pathway component in
tracheal cell migration is illustrated in Fig. 8.
Evidence of a role of DA in receptor endocytosis has
emerged recently. For instance, DA can promote VEGFR
endocytosis in cultured human endothelial cells (Basu et al.,
2001). DA D3 receptor-mediated modulation of GABAA
receptor (Chen et al., 2006) and DA-regulated endocytosis of
the renal cell Na+, K+-ATPase (Efendiev et al., 2002) are
similarly dynamin-mediated events. Why is a neurohormone
also a mediator of endocytosis in other cell types? It is
interesting to consider the possibility that the endocytic activity
of DA may in fact be its ancestral function, which was adopted
by the neurons and tubular cells later. Indeed, primitive, nerve-
less multicellular organisms such as sponge can produce
dopamine (Liu et al., 2004). The precise mechanism(s) by
which DA regulates dynamin assembly is not yet clear.
However, Efendiev et al. (2002) reported that DA signaling
promotes dynamin stabilization and assembly at the plasma
membrane in cultured human kidney cells–and thus endocy-
tosis–by activating protein phosphatase 2A which depho-
sphorylates dynamin-2. It is possible that a similar mechanism
of action occurs in the tracheal cells and future experiments will
help to address this possibility.
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